Relationship of clomiphene dose and patient weight to successful treatment

• Published in: Human reproduction (Oxford) 1997-03, Vol.12 (3), p.449-453
• Main Authors: Dickey, R P, Taylor, S N, Curole, D N, Rye, P H, Lu, P Y, Pyrzak, R
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Birth control; Body Weight; Clomiphene - administration & dosage; Dose-Response Relationship, Drug; Endometrium - drug effects; Female; Fertility Agents, Female - administration & dosage; Gynecology. Andrology. Obstetrics; Humans; Medical sciences; Ovarian Follicle - drug effects; Ovulation Induction - methods; Pregnancy - drug effects; Sterility. Assisted procreation; Treatment Outcome
• ISSN: 0268-1161; 1460-2350
• DOI: 10.1093/humrep/12.3.449

Our objective was to examine the relationship between patient weight and the dose of clomiphene required for pregnancy so as to assess the validity of recommendations that the dose of clomiphene be limited to 100 mg. We retrospectively analysed the weight-dose relationship in 1681 clomiphene pregnancies and the relationship between dose and pregnancy, births, multiple births, number of pre-ovulatory follicles and endometrial thickness in 2841 cycles of clomiphene treatment, 25-250 mg, for 5 days before intrauterine insemination (IUI). Doses of clomiphene >100 mg/day were used before pregnancies in 27.4% of patients who weighed >90 kg and in 14.7% of all pregnancies. In IUI cycles, pregnancies and births, but not multiple births or abortions, were related to dose. An increase in dose from 25 to 100 mg resulted in higher pregnancy and birth rates, and in an increase in the average number of pre-ovulatory follicles > or =12 mm in diameter, from 2.0 to 2.8, with no additional increase at higher doses. Endometrial thickness and cycle day of insemination were not related to dose. We conclude that doses of clomiphene may safely be increased beyond 100 mg, and that doses > or =100 mg are required in significant numbers of patients.